The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(4-Hydroxypiperidin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one ID: ALA4744768
PubChem CID: 147874387
Max Phase: Preclinical
Molecular Formula: C27H36N4O3
Molecular Weight: 464.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCC1Cc2cc(-n3nc(C)c4c3CC(C)(C)CC4=O)cc(N3CCC(O)CC3)c2C(=O)N1
Standard InChI: InChI=1S/C27H36N4O3/c1-5-6-18-11-17-12-19(31-22-14-27(3,4)15-23(33)24(22)16(2)29-31)13-21(25(17)26(34)28-18)30-9-7-20(32)8-10-30/h12-13,18,20,32H,5-11,14-15H2,1-4H3,(H,28,34)
Standard InChI Key: HZFRPINRGHBYHW-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
16.0489 -2.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6589 -2.8183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8349 -2.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7312 -4.4215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0123 -4.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3007 -4.4212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0116 -3.1809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5991 -1.9100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3442 -2.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4263 -1.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6801 -2.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4885 -2.8767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7952 -1.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9810 -1.2925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7282 -0.5072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1168 -1.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3098 -5.2432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5920 -5.6491 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2996 -6.8935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0180 -5.6579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0123 -6.4787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7164 -6.8917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4306 -6.4885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4363 -5.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7277 -5.2501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1416 -6.9069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8595 -6.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5706 -6.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8814 -5.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1657 -5.6296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1541 -6.4544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8643 -6.8753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5861 -6.4713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4332 -6.8541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
25 4 2 0
4 5 1 0
5 6 2 0
6 17 1 0
5 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 7 1 0
10 11 2 0
10 14 1 0
11 12 1 0
12 1 1 0
1 13 1 0
13 14 1 0
14 15 2 0
8 16 1 0
21 19 2 0
20 17 2 0
17 18 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
23 26 1 0
26 27 1 0
27 28 1 0
18 29 1 0
18 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
31 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 464.61Molecular Weight (Monoisotopic): 464.2787AlogP: 3.75#Rotatable Bonds: 4Polar Surface Area: 87.46Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.05CX LogP: 2.77CX LogD: 2.77Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.72Np Likeness Score: -0.20
References 1. Mishra SJ,Liu W,Beebe K,Banerjee M,Kent CN,Munthali V,Koren J,Taylor JA,Neckers LM,Holzbeierlein J,Blagg BSJ. (2021) The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition., 64 (3.0): [PMID:33428418 ] [10.1021/acs.jmedchem.0c01700 ]